Diseases, Conditions, Syndromes

Guidance updated for managing C. difficile infection in adults

(HealthDay)—Use of fidaxomicin and bezlotoxumab is suggested in specific cases for management of Clostridioides difficile infection (CDI), according to a clinical practice guideline update issued by the Infectious Diseases ...

Medications

In search of clues to fight antibiotic resistance

To combat the rise of drug-resistant bacteria, researchers are examining how one superbug adapts to fight an antibiotic of last resort, hoping to find clues that can prolong the drug's effectiveness.

Diseases, Conditions, Syndromes

Hospital cleaning trial cuts infections

A major trial of a bundle of hospital cleaning practices in 11 Australian hospitals has made significant reductions in healthcare associated infections and demonstrated cost-benefits.

Diseases, Conditions, Syndromes

Vancomycin + piperacillin / tazobactam ups kidney risk

(HealthDay)—For hospitalized children, coadministration of intravenous (IV) vancomycin and piperacillin/tazobactam is associated with increased risk of acute kidney injury (AKI), according to a study published online Oct. ...

Diseases, Conditions, Syndromes

Fecal microbiota transplant cost-effective for preventing CDI

(HealthDay)—Use of fecal microbiota transplantation (FMT) is cost-effective for recurrent Clostridium difficile infection (CDI), according to a study published in the December issue of the Journal of Gastroenterology and ...

page 2 from 7